Participants who drank the plant-compound-dense beverage daily for four weeks yields noticeable drops in systemic inflammatory markers.
The report adds that a clinical trial administered a formulated tomato-soy beverage daily for four weeks to enrolled participants.
The filing also states systemic inflammatory markers tied to obesity declined measurably during the intervention period.
Plant compounds in tomatoes and soy are thought to mediate the anti-inflammatory response. Spokespersons referred inquiries to previously issued statements.
Researchers said dietary approaches may complement medical treatment for obesity-related inflammation. Further updates are expected as proceedings continue.
Named entities in source reporting include clinical trial participants.
Source documents list dates, agencies, and procedural steps referenced in the summary above.
Created by Ayen Stabel.
Stabel is AI and can make mistakes.
Sources:
https://www.sciencedaily.com/news/health_medicine/tomato-soy-juice-obesity-trial